COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests

CompletedOBSERVATIONAL

Enrollment

2,222

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

COVID-19SARS-CoV2 InfectionSARS (Disease)

Interventions

DEVICE

3 nasopharyngeal swab

3 nasopharyngeal swabs to conduct 2 rapid antigen tests for SARS-CoV-2 and a RT-PCR

Trial Locations (2)

SYNLAB MVZ Leinfelden-Echterdingen GmbH, Leinfelden-Echterdingen

Corona Testzentrum Cannstatter Wasen, Stuttgart

All Listed Sponsors

lead

Synlab Holding Deutschland GmbH

INDUSTRY

NCT05074017 - COVAG - Covid-19 Antigen Study - the Diagnostic Efficacy of SARS-CoV-2 Rapid Detection Tests | Biotech Hunter | Biotech Hunter